Chocolate, other products recalled by company given highest risk level by FDA
Cal Yee Farm LLC is recalling chocolate and other products. Some have been given a Class I classification by the FDA which is their highest risk level.
news10nbc22m
FDA approves JournaVX, a non-opioid pain relief option for adults
A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...
KRIV25m
FDA approves 'non-opioid' painkillers
Journavx (suzetrigine) is said to reduce pin by "targeting a pain-signaling pathway involving sodium channels in the ...
Hosted on MSN30m
Non-Opioid Pain Medication Journavx Gets FDA Approval
The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
Science News33m
A new kind of non-opioid painkiller gets FDA approval
Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
Becker's Hospital Review33m
FDA approves 1st-of-its-kind non-opioid pain medication
The FDA has approved suzetrigine, a new, non-opioid medication for adults with moderate to severe acute pain.
Vertex Pharmaceuticals' non-opioid pain medication gets FDA approval
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
The American Journal of Managed Care41m
FDA Approves First HER2-Ultralow Companion Diagnostic, Expanding Treatment Eligibility
Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...
FDA approves new pain medicine as opioid alternative. What to know about Journavx
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
Chocolate Recall Updated to Highest Risk Level, FDA Warns Consumption Could Cause Death
Cal Yee Farms' dark chocolate walnuts, dark chocolate almonds and dark chocolate apricots have been given a Class 1 recall ...
Managed Healthcare Executive1h
FDA Approves Journavx as a New Non-Opioid Pain Med for Acute Pain Relief
The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid medication for treating moderate to severe acute pain in adults. Journavx, approved ...
No Opioids, No Addiction: FDA Approves First New Type of Painkiller in Decades
Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...